Grant: Operating Grant: Health Systems Research on H1N1
University of Toronto
$97,656.00
The use of evidence in developing public health policies for H1N1
FY 2009-10
Summary
A key feature of the public health system is the ability to take scientific evidence and translate into public health policies that will protect the population. Given the nature of public health and the need to respond quickly to emerging threats, evidence often needs to be translated and applied rapidly. When responding to a novel virus, policies are set under time constraints and uncertainty which can limit the ability to control the outbreak and result in unintended consequences, such as lack of public confidence. The H1N1 pandemic has highlighted challenges of using evidence during a public health emergency and the importance of understanding this process to identify barriers and modifiable influences. The purpose of this study is to gain an in-depth understanding of the factors that affected the use of evidence for public health decisions in Canada during the H1N1 pandemic. Specifically to: identify the range of evidence used, identify barriers that limited the use of evidence for decision-making, and identify factors that influenced how evidence was used and/or interpreted. Policies to be studied include: use of adjuvant vaccine, pandemic vaccine priority groups and sequencing, school closures, and personal protective equipment. Data will be collected though policy document analysis and through key informant interviews with public health decision-makers at federal, provincial and regional levels. This study will look in depth at the question of how we did real-time policy with real-time science. As a result, the findings will provide the basis for more effective and transparent use of evidence in addition to identifying barriers in the public health system. This will be a contribution for public health stakeholders to improve policymaking, particularly during a pandemic or other emergency setting. This study will support the continued commitment by government to ensure the public health system in Canada can effectively respond to future challenges.
Department
Program
Operating Grant: Health Systems Research on H1N1
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
198374
Name
Crowcroft Natasha S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Operating Grant: Health Systems Research on H1N1
Projecttitle
The use of evidence in developing public health policies for H1N1
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$97,656
Cihrequipment2
$0
Programname2
Operating Grant: Health Systems Research on H1N1
Keyworddelim
Decision-Making; Evidence; Knowledge Tranlsation; Pandemic H1n1; Public Health Policy; Public Health System
Abstract
A key feature of the public health system is the ability to take scientific evidence and translate into public health policies that will protect the population. Given the nature of public health and the need to respond quickly to emerging threats, evidence often needs to be translated and applied rapidly. When responding to a novel virus, policies are set under time constraints and uncertainty which can limit the ability to control the outbreak and result in unintended consequences, such as lack of public confidence. The H1N1 pandemic has highlighted challenges of using evidence during a public health emergency and the importance of understanding this process to identify barriers and modifiable influences. The purpose of this study is to gain an in-depth understanding of the factors that affected the use of evidence for public health decisions in Canada during the H1N1 pandemic. Specifically to: identify the range of evidence used, identify barriers that limited the use of evidence for decision-making, and identify factors that influenced how evidence was used and/or interpreted. Policies to be studied include: use of adjuvant vaccine, pandemic vaccine priority groups and sequencing, school closures, and personal protective equipment. Data will be collected though policy document analysis and through key informant interviews with public health decision-makers at federal, provincial and regional levels. This study will look in depth at the question of how we did real-time policy with real-time science. As a result, the findings will provide the basis for more effective and transparent use of evidence in addition to identifying barriers in the public health system. This will be a contribution for public health stakeholders to improve policymaking, particularly during a pandemic or other emergency setting. This study will support the continued commitment by government to ensure the public health system in Canada can effectively respond to future challenges.
Competitiondate
201001
Approvedterm2
1 yr 0 mth
Pinamesdelim
Crowcroft, Natasha S
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Population &Publ Hlth~ $48,828~ $0~Knowledge Translation Branch~ $48,828~ $0~